Wall enhancement on black-blood MRI is independently associated with symptomatic status of unruptured intracranial saccular aneurysm.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 02 01 2020
accepted: 01 07 2020
revised: 19 05 2020
pubmed: 16 7 2020
medline: 1 4 2021
entrez: 16 7 2020
Statut: ppublish

Résumé

This study aims to investigate whether aneurysm wall enhancement (AWE) is independently associated with symptomatic status of unruptured intracranial aneurysms (UIAs). One hundred thirty-nine consecutive patients (67 male, mean age 58 ± 11 years) with 79 symptomatic and 87 asymptomatic UIAs were imaged using black-blood MRI pre- and post-gadolinium contrast administration and 3D DSA. Symptoms related to aneurysms were identified including cranial nerve deficits and headache. AWE grade and area were characterized, and aneurysm size was measured on DSA. Multivariate binary logistic regression analysis was used to identify factors associated with symptoms. Further subgroup analysis was performed for aneurysms size < 10 mm. Symptomatic UIAs had significantly larger aneurysm size (11.2 ± 6.2 mm vs. 6.4 ± 3.3 mm), enhancement grade (1.3 ± 0.6 vs. 0.4 ± 0.6), enhancement area (2.0 ± 0.9 vs. 0.4 ± 0.7), and higher prevalence of thick enhancement (39% vs. 3%) compared with asymptomatic UIAs, all p < 0.001. In multivariate analysis, only AWE area (odds ratio [OR] 6.9, 95% confidence interval [4.0, 11.7]) was independently associated with symptoms. AWE area had an area under curve (AUC) value of 0.888, with 72.2% sensitivity and 92.0% specificity for symptoms, which was superior to aneurysm size (AUC of 0.771, with 75.9% sensitivity and 65.5% specificity). In the subgroup analysis of aneurysms smaller than 10 mm (n = 118), AWE area (OR, 7.0, p < 0.001) remained the only independent risk factor associated with symptoms. Larger AWE area is independently associated with symptomatic UIAs, which may provide additional value to guide UIA management and improve patient outcomes. • Symptomatic intracranial aneurysms are larger and more often demonstrate significant wall enhancement than asymptomatic aneurysms. • Larger wall enhancement area is independently associated with symptomatic intracranial aneurysm.

Identifiants

pubmed: 32666320
doi: 10.1007/s00330-020-07063-6
pii: 10.1007/s00330-020-07063-6
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6413-6420

Subventions

Organisme : NHLBI NIH HHS
ID : K99HL136883
Pays : United States
Organisme : Natural Science Foundation of Liaoning Province
ID : 2019-BS-267
Organisme : NHLBI NIH HHS
ID : K99HL136883
Pays : United States

Références

Wiebers DO, Whisnant JP, Huston J 3rd et al (2003) Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362:103–110
doi: 10.1016/S0140-6736(03)13860-3
Thompson BG, Brown RD Jr, Amin-Hanjani S et al (2015) Guidelines for the management of patients with unruptured intracranial aneurysms: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46:2368–2400
doi: 10.1161/STR.0000000000000070
Teo M, St George EJ (2016) Radiologic surveillance of untreated unruptured intracranial aneurysms: a single surgeon’s experience. World Neurosurg 90:20–28
doi: 10.1016/j.wneu.2016.02.008
Wang X, Zhu C, Leng Y, Degnan AJ, Lu J (2019) Intracranial aneurysm wall enhancement associated with aneurysm rupture: a systematic review and meta-analysis. Acad Radiol 26:664–673
doi: 10.1016/j.acra.2018.05.005 pubmed: 29908979 pmcid: 29908979
Edjlali M, Guédon A, Ben Hassen W et al (2018) Circumferential thick enhancement at vessel wall MRI has high specificity for intracranial aneurysm instability. Radiology 289:181–187
doi: 10.1148/radiol.2018172879
Vergouwen MDI, Backes D, van der Schaaf IC et al (2019) Gadolinium enhancement of the aneurysm wall in unruptured intracranial aneurysms is associated with an increased risk of aneurysm instability: a follow-up study. AJNR Am J Neuroradiol 40:1112–1116
doi: 10.3174/ajnr.A6105 pubmed: 7048551 pmcid: 7048551
Matsushige T, Shimonaga K, Ishii D et al (2019) Vessel Wall imaging of evolving unruptured intracranial aneurysms. Stroke 50:1891–1894
doi: 10.1161/STROKEAHA.119.025245
Fu Q, Guan S, Liu C, Wang K, Cheng J (2018) Clinical significance of circumferential Aneurysmal Wall enhancement in symptomatic patients with unruptured intracranial aneurysms: a high-resolution MRI study. Clin Neuroradiol 28:509–514
doi: 10.1007/s00062-017-0598-4
Larsen N, von der Brelie C, Trick D et al (2018) Vessel wall enhancement in unruptured intracranial aneurysms: an indicator for higher risk of rupture? High-resolution MR imaging and correlated histologic findings. AJNR Am J Neuroradiol 39:1617–1621
doi: 10.3174/ajnr.A5731 pubmed: 30026386
Quan K, Song J, Yang Z et al (2019) Validation of wall enhancement as a new imaging biomarker of unruptured cerebral aneurysm. Stroke 50:1570–1573
doi: 10.1161/STROKEAHA.118.024195 pubmed: 31035900
Cianfoni A, Pravatà E, De Blasi R, Tschuor CS, Bonaldi G (2013) Clinical presentation of cerebral aneurysms. Eur J Radiol 82:1618–1622
doi: 10.1016/j.ejrad.2012.11.019 pubmed: 23238357
Liu X, Zhang Z, Zhu C et al (2020) Wall enhancement of intracranial saccular and fusiform aneurysms may differ in intensity and extension: a pilot study using 7-T high-resolution black-blood MRI. Eur Radiol 30:301–307
doi: 10.1007/s00330-019-06275-9 pubmed: 31218429
Zhu C, Wang X, Degnan AJ et al (2018) Wall enhancement of intracranial unruptured aneurysm is associated with increased rupture risk and traditional risk factors. Eur Radiol 28:5019–5026
doi: 10.1007/s00330-018-5522-z pubmed: 29872913
Tian B, Toossi S, Eisenmenger L et al (2019) Visualizing wall enhancement over time in unruptured intracranial aneurysms using 3D vessel wall imaging. J Magn Reson Imaging 50:193–200
doi: 10.1002/jmri.26553 pubmed: 30390363
Portanova A, Hakakian N, Mikulis DJ, Virmani R, Abdalla WM, Wasserman BA (2013) Intracranial vasa vasorum: insights and implications for imaging. Radiology 267:667–679
doi: 10.1148/radiol.13112310 pubmed: 23704290
Kalsoum E, Chabernaud Negrier A, Tuilier T et al (2018) Blood flow mimicking aneurysmal wall enhancement: a diagnostic pitfall of vessel wall MRI using the postcontrast 3D Turbo spin-echo MR imaging sequence. AJNR Am J Neuroradiol 39:1065–1067
doi: 10.3174/ajnr.A5616 pubmed: 29599170 pmcid: 7410621
Xie Y, Yang Q, Xie G, Pang J, Fan Z, Li D (2016) Improved black-blood imaging using DANTE-SPACE for simultaneous carotid and intracranial vessel wall evaluation. Magn Reson Med 75:2286–2294
doi: 10.1002/mrm.25785 pubmed: 26152900
Zhu C, Graves MJ, Yuan J, Sadat U, Gillard JH, Patterson AJ (2014) Optimization of improved motion-sensitized driven-equilibrium (iMSDE) blood suppression for carotid artery wall imaging. J Cardiovasc Magn Reson 16:61
doi: 10.1186/s12968-014-0061-5 pubmed: 25160911 pmcid: 4145260

Auteurs

Chengcheng Zhu (C)

Department of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA.

Xinrui Wang (X)

Department of Radiology, Changhai Hospital, Shanghai, China.
Department of Radiology, General Hospital of Northern Theatre Command, Shenyang, China.

Laura Eisenmenger (L)

Department of Radiology, University of Wisconsin, Madison, WI, USA.

Zhang Shi (Z)

Department of Radiology, Changhai Hospital, Shanghai, China.

Andrew Degnan (A)

Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Bing Tian (B)

Department of Radiology, Changhai Hospital, Shanghai, China.

Qi Liu (Q)

Department of Radiology, Changhai Hospital, Shanghai, China.

Christopher Hess (C)

Department of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA.

David Saloner (D)

Department of Radiology and Biomedical Imaging, UCSF, San Francisco, CA, USA.

Jianping Lu (J)

Department of Radiology, Changhai Hospital, Shanghai, China. cjr.lujianping@vip.163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH